866-997-4948(US-Canada Toll Free)

Global Market Study on Progressive Multifocal Leukoencephalopathy Treatment: HIV/AIDS Indication to Dominate in Terms of Value Through 2026 Owing to Government Initiatives and Support for HIV Associated PML Treatment

Published By :

Persistence Market Research

Published Date : Aug 2018

Category :

Therapeutic Area

No. of Pages : 208 Pages

Large unmet need for treatment of progressive multifocal leukoencephalopathy (PML) is the key underpinning factor for the evolution of the market. Recent strides have been bolstered by an attractive drug pipeline, where the focus is to develop drug candidates for the prophylaxis of HIV/AIDS indication, particularly in North America and Europe. Players in key markets might reap gains from the need for therapies for Human polyomavirus 2. All these factors and more will help the PML market to clock a CAGR of 2.8% during 2018–2026.



Request summary of this Report

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

This Persistence Market Research (PMR) report examines the ‘Global Progressive Multifocal Leukoencephalopathy Treatment Market’ for the period 2018–2026. The primary objective of the report is to offer updates and information related to market opportunities in the global progressive multifocal leukoencephalopathy treatment market.

The Progressive Multifocal Leukoencephalopathy Treatment Market is Segmented Based on:

  • Drug Type
  • Indication
  • Distribution Channel
  • Region

This report covers the global progressive multifocal leukoencephalopathy treatment market performance in terms of revenue contribution from various segments. The global progressive multifocal leukoencephalopathy treatment market report begins with an overview and definitions. The market viewpoints section underlines macro-economic factors influencing the growth of the global progressive multifocal leukoencephalopathy treatment market along with detailed opportunity analysis of the market. This is then followed by the key drivers, restraints and trends of the global progressive multifocal leukoencephalopathy treatment market.

The global progressive multifocal leukoencephalopathy treatment market is segmented based on drug type, indication, distribution channel and regions. Based on drug type, the global progressive multifocal leukoencephalopathy treatment market is segmented into anti-retroviral therapy, antiviral/anti JCV and other symptomatic. Based on indication, the global progressive multifocal leukoencephalopathy treatment market is segmented into HIV/AIDS, organ transplantation, multiple sclerosis and hematological malignancies. Based on distribution channel, the global progressive multifocal leukoencephalopathy treatment market is segmented into hospital pharmacies, drug stores and retail pharmacies. Geographically, the global progressive multifocal leukoencephalopathy treatment market is segmented into North America (the U.S. & Canada), Latin America (Brazil, Mexico, and Rest of Latin America), Europe (Germany, France, the U.K., Italy, Spain, Russia and Rest of Europe), Asia Pacific (China, India, Australia, Japan, ASEAN and Rest of Asia Pacific), Japan and Middle-East and Africa (GCC Countries, South Africa and Rest of MEA).

A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index. The forecast of the progressive multifocal leukoencephalopathy treatment market by country, drug type, indication and distribution channel is represented in a tabular form for each region. This section will help to understand the present scenario and opportunities of the progressive multifocal leukoencephalopathy treatment market in major countries by each segment.

In the next section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view of the key competitor firms in order to access the key differentiators among the competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to a market segment. The detailed profiles of players operating in the progressive multifocal leukoencephalopathy treatment market are also provided in the report, which highlight company description, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

The next section of the report highlights the market outlook for 2018–2026 and sets the forecast within the context of the progressive multifocal leukoencephalopathy treatment market by region. A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index.

The above sections – by drug type, indication and distribution channel – evaluate the historic market analysis and growth prospects of the progressive multifocal leukoencephalopathy treatment market for the period 2018–2026. We have considered 2017 as the base year and provided data for the forecast period.

The final section of the report represents the global scenario of the progressive multifocal leukoencephalopathy treatment market along with y-o-y growth and market forecast till 2026. This section also evaluates the global market opportunity over the forecast period as well as the absolute dollar opportunity for each year. This section will help to understand the overall growth of the progressive multifocal leukoencephalopathy treatment market and the opportunity analysis for every year over the forecast period.

To arrive at the market size, bottom-up approach is used to validate the total market size obtained for the progressive multifocal leukoencephalopathy treatment market. The forecast presented in the report provides total revenue of the progressive multifocal leukoencephalopathy treatment market over 2018–2026. PMR has used a triangulation methodology that is primarily based on experimental techniques, such as patient-level data to obtain precise market estimations for progressive multifocal leukoencephalopathy treatment market and insights on specific country/regions. The country-specific data is again analyzed to derive data at a regional level and then at the global level. This methodology ensures high quality and accuracy of information.

The factors considered while developing the estimates of the progressive multifocal leukoencephalopathy treatment market are disease epidemiology, treatment seeking rate, ratio of population prescribed with different level of treatment differently for HIV/AIDS, multiple sclerosis, organ transplant and hematological malignancies.

The average selling price (US$) is derived by using weighted average pricing methodology.

On the other hand, PMR has also analyzed the market by considering the revenue from the key players operating a segment. The key players are segmented at the tier level with respect to their revenue, product portfolio and geographical presence. This process involves analysis of various annual reports of companies, investor presentations, SEC filings, 10k reports, earning call transcripts and press releases. This task is done to fetch substantial information about the key players, their respective revenues and estimate their respective market share.

Revenue growth of the key market players is analyzed over the historical period and qualitative assessment of new treatment pattern and use of combination therapy has been made in order to validate and align the resultant market numbers. The market structure is closely studied and analyzed at the regional level to map and ascertain incremental $ opportunity for companies, for instance, supply from domestic/regional players, small-scale enterprises or unorganized segments is also taken into consideration to arrive at the final market numbers.

While forecasting the size of the progressive multifocal leukoencephalopathy treatment market, we have considered the impact of several factors such as per capital healthcare expenditure, disposable income, new testing methods and treatment pattern, generic penetration across all regions, etc. However, quantifying the market across the aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalizing them after the forecast has been completed. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

Table of Content

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy

3. Progressive Multifocal Leukoencephalopathy Treatment Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Trends

5. Key Inclusions
5.1. Key Regulations
5.2. Pipeline Analysis

6. North America Progressive Multifocal Leukoencephalopathy Treatment Market Analysis 2013-2017 and Forecast 2018–2026
6.1. Introduction
6.2. Historical Market Size (US$ Mn) & Analysis By Country, 2013-2017
6.2.1. U.S.
6.2.2. Canada
6.3. Market Size (US$ Mn) & Forecast By Country, 2018–2026
6.4. Historical Market Size (US$ Mn) By Drug Type, 2013-2017
6.4.1. Anti-retroviral Therapy
6.4.2. Antiviral/Anti JCV
6.4.3. Other Symptomatic
6.5. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
6.6. Historical Market Size (US$ Mn) By Indication, 2013-2017
6.6.1. HIV/AIDS
6.6.2. Organ Transplantation
6.6.3. Multiple Sclerosis
6.6.4. Hematological Malignancies
6.7. Market Size (US$ Mn) Forecast By Indication, 2018–2026
6.8. Historical Market Size (US$ Mn) and Trend Analysis By Distribution Channel, 2013-2017
6.8.1. Hospital Pharmacies
6.8.2. Drug Stores
6.8.3. Retail Pharmacies
6.9. Market Size (US$ Mn) and Forecast By Distribution Channel, 2018–2026
6.10. Market Attractiveness Analysis
6.10.1. By Country
6.10.2. By Drug Type
6.10.3. By Indication
6.10.4. By Distribution Channel
6.11. Drivers and Restraints: Impact Analysis

7. Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Analysis 2013-2017and Forecast 2018–2026
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Trends and Analysis By Country, 2013-2017
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Market Size (US$ Mn) & Forecast By Country, 2018–2026
7.4. Historical Market Size (US$ Mn) By Drug Type, 2013-2017
7.4.1. Anti-retroviral Therapy
7.4.2. Antiviral/Anti JCV
7.4.3. Other Symptomatic
7.5. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
7.6. Historical Market Size (US$ Mn) By Indication, 2013-2017
7.6.1. HIV/AIDS
7.6.2. Organ Transplantation
7.6.3. Multiple Sclerosis
7.6.4. Hematological Malignancies
7.7. Market Size (US$ Mn) Forecast By Indication, 2018–2026
7.8. Historical Market Size (US$ Mn) and Trend Analysis By Distribution Channel, 2013-2017
7.8.1. Hospital Pharmacies
7.8.2. Drug Stores
7.8.3. Retail Pharmacies
7.9. Market Size (US$ Mn) and Forecast By Distribution Channel, 2018–2026
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Drug Type
7.10.3. By Indication
7.10.4. By Distribution Channel
7.11. Drivers and Restraints: Impact Analysis

8. Europe Progressive Multifocal Leukoencephalopathy Treatment Market Analysis 2013-2017and Forecast 2018–2026
8.1. Introduction
8.2. Regional Trends
8.3. Historical Market Size (US$ Mn) and Trend Analysis By Country, 2013-2017
8.3.1. Germany
8.3.2. U.K.
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Rest of Europe
8.4. Market Size (US$ Mn) & Forecast By Country, 2018–2026
8.5. Historical Market Size (US$ Mn) By Drug Type, 2013-2017
8.5.1. Anti-retroviral Therapy
8.5.2. Antiviral/Anti JCV
8.5.3. Other Symptomatic
8.6. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
8.7. Historical Market Size (US$ Mn) By Indication, 2013-2017
8.7.1. HIV/AIDS
8.7.2. Organ Transplantation
8.7.3. Multiple Sclerosis
8.7.4. Hematological Malignancies
8.8. Market Size (US$ Mn) Forecast By Indication, 2018–2026
8.9. Historical Market Size (US$ Mn) and Trend Analysis By Distribution Channel, 2013-2017
8.9.1. Hospital Pharmacies
8.9.2. Drug Stores
8.9.3. Retail Pharmacies
8.10. Market Size (US$ Mn) and Forecast By Distribution Channel, 2018–2026
8.11. Market Attractiveness Analysis
8.11.1. By Country
8.11.2. By Drug Type
8.11.3. By Indication
8.11.4. By Distribution Channel
8.12. Drivers and Restraints: Impact Analysis

9. Asia Pacific Excluding China Progressive Multifocal Leukoencephalopathy Treatment Market Analysis 2013-2017 and Forecast 2018–2026
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013-2017
9.2.1. China
9.2.2. India
9.2.3. Australia
9.2.4. Japan
9.2.5. ASEAN
9.2.6. Rest of Asia Pacific
9.3. Market Size (US$ Mn) & Forecast By Country, 2018–2026
9.4. Historical Market Size (US$ Mn) By Drug Type, 2013-2017
9.4.1. Anti-retroviral Therapy
9.4.2. Antiviral/Anti JCV
9.4.3. Other Symptomatic
9.5. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
9.6. Historical Market Size (US$ Mn) By Indication, 2013-2017
9.6.1. HIV/AIDS
9.6.2. Organ Transplantation
9.6.3. Multiple Sclerosis
9.6.4. Hematological Malignancies
9.7. Market Size (US$ Mn) Forecast By Indication, 2018–2026
9.8. Historical Market Size (US$ Mn) and Trend Analysis By Distribution Channel, 2013-2017
9.8.1. Hospital Pharmacies
9.8.2. Drug Stores
9.8.3. Retail Pharmacies
9.9. Market Size (US$ Mn) and Forecast By Distribution Channel, 2018–2026
9.10. Market Attractiveness Analysis
9.10.1. By Country
9.10.2. By Drug Type
9.10.3. By Indication
9.10.4. By Distribution Channel
9.11. Drivers and Restraints: Impact Analysis

10. Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Analysis 2013-2017and Forecast 2018–2026
10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Trend Analysis By Country, 2013-2017
10.2.1. GCC Countries
10.2.2. South Africa
10.2.3. Rest of MEA
10.3. Market Size (US$ Mn) & Forecast By Country, 2018–2026
10.4. Historical Market Size (US$ Mn) By Drug Type, 2013-2017
10.4.1. Anti-retroviral Therapy
10.4.2. Antiviral/Anti JCV
10.4.3. Other Symptomatic
10.5. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
10.6. Historical Market Size (US$ Mn) By Indication, 2013-2017
10.6.1. HIV/AIDS
10.6.2. Organ Transplantation
10.6.3. Multiple Sclerosis
10.6.4. Hematological Malignancies
10.7. Market Size (US$ Mn) Forecast By Indication, 2018–2026
10.8. Historical Market Size (US$ Mn) and Trend Analysis By Distribution Channel, 2013-2017
10.8.1. Hospital Pharmacies
10.8.2. Drug Stores
10.8.3. Retail Pharmacies
10.9. Market Size (US$ Mn) and Forecast By Distribution Channel, 2018–2026
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Drug Type
10.10.3. By Indication
10.10.4. By Distribution Channel
10.11. Drivers and Restraints: Impact Analysis

11. Forecast Factors: Relevance and Impact

12. Competition Analysis
12.1. Competition Dashboard
12.2. Company Deep Dive
12.2.1. Pfizer, Inc.
12.2.1.1. Overview
12.2.1.2. Product and Application Portfolio
12.2.1.3. Production Footprint
12.2.1.4. Sales Footprint
12.2.1.5. Channel Footprint
12.2.1.6. Strategy
12.2.1.6.1. Marketing Strategy
12.2.1.6.2. Product Strategy
12.2.1.6.3. Channel Strategy
12.2.2. F. Hoffman - La Roche Ltd.
12.2.2.1. Overview
12.2.2.2. Product and Application Portfolio
12.2.2.3. Production Footprint
12.2.2.4. Sales Footprint
12.2.2.5. Channel Footprint
12.2.2.6. Strategy
12.2.2.6.1. Marketing Strategy
12.2.2.6.2. Product Strategy
12.2.2.6.3. Channel Strategy
12.2.3. Gilead Sciences, Inc.
12.2.3.1. Overview
12.2.3.2. Product and Application Portfolio
12.2.3.3. Production Footprint
12.2.3.4. Sales Footprint
12.2.3.5. Channel Footprint
12.2.3.6. Strategy
12.2.3.6.1. Marketing Strategy
12.2.3.6.2. Product Strategy
12.2.3.6.3. Channel Strategy
12.2.4. GlaxoSmithKline plc
12.2.4.1. Overview
12.2.4.2. Product and Application Portfolio
12.2.4.3. Production Footprint
12.2.4.4. Sales Footprint
12.2.4.5. Channel Footprint
12.2.4.6. Strategy
12.2.4.6.1. Marketing Strategy
12.2.4.6.2. Product Strategy
12.2.4.6.3. Channel Strategy
12.2.5. Sanofi S.A.
12.2.5.1. Overview
12.2.5.2. Product and Application Portfolio
12.2.5.3. Production Footprint
12.2.5.4. Sales Footprint
12.2.5.5. Channel Footprint
12.2.5.6. Strategy
12.2.5.6.1. Marketing Strategy
12.2.5.6.2. Product Strategy
12.2.5.6.3. Channel Strategy
12.2.6. Allergan plc (Actavis plc)
12.2.6. Overview
12.2.6.2. Product and Application Portfolio
12.2.6.3. Production Footprint
12.2.6.4. Sales Footprint
12.2.6.5. Channel Footprint
12.2.6.6. Strategy
12.2.6.6.1. Marketing Strategy
12.2.6.6.2. Product Strategy
12.2.6.6.3. Channel Strategy
12.2.7. Novartis AG
12.2.7.1. Overview
12.2.7.2. Product and Application Portfolio
12.2.7.3. Production Footprint
12.2.7.4. Sales Footprint
12.2.7.5. Channel Footprint
12.2.7.6. Strategy
12.2.7.6.1. Marketing Strategy
12.2.7.6.2. Product Strategy
12.2.7.6.3. Channel Strategy
12.2.8. Mylan N.V.
12.2.8.1. Overview
12.2.8.2. Product and Application Portfolio
12.2.8.3. Production Footprint
12.2.8.4. Sales Footprint
12.2.8.5. Channel Footprint
12.2.8.6. Strategy
12.2.8.6.1. Marketing Strategy
12.2.8.6.2. Product Strategy
12.2.8.6.3. Channel Strategy
12.2.9. AbbVie Inc.
12.2.9.1. Overview
12.2.9.2. Product and Application Portfolio
12.2.9.3. Production Footprint
12.2.9.4. Sales Footprint
12.2.9.5. Channel Footprint
12.2.9.6. Strategy
12.2.9.6.1. Marketing Strategy
12.2.9.6.2. Product Strategy
12.2.9.6.3. Channel Strategy
12.2.10. Bristol-Myers Squibb Company
12.2.10.1. Overview
12.2.10.2. Product and Application Portfolio
12.2.10.3. Production Footprint
12.2.10.4. Sales Footprint
12.2.10.5. Channel Footprint
12.2.10.6. Strategy
12.2.10.6.1. Marketing Strategy
12.2.10.6.2. Product Strategy
12.2.10.6.3. Channel Strategy

13. Global Progressive Multifocal Leukoencephalopathy Treatment Market Analysis 2013-2017and Forecast 2018–2026, By Region
13.1. Introduction/Key Findings
13.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013-2017
13.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. Asia Pacific
13.3.5. Middle East & Africa
13.4. Market Attractiveness Analysis By Region

14. Global Progressive Multifocal Leukoencephalopathy Treatment Market Analysis 2013-2017and Forecast 2018–2026, By Drug Type
14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Mn) By Drug Type, 2013-2017
14.2.1. Anti-retroviral Therapy
14.2.2. Antiviral/Anti JCV
14.2.3. Other Symptomatic
14.3. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
14.4. Market Attractiveness Analysis By Drug Type

15. Global Progressive Multifocal Leukoencephalopathy Treatment Market Analysis 2013-2017and Forecast 2018–2026, By Indication
15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Mn) By Drug Type, 2013-2017
15.2.1. HIV/AIDS
15.2.2. Organ Transplantation
15.2.3. Multiple Sclerosis
15.2.4. Hematological Malignancies
15.3. Market Size (US$ Mn) Forecast By Indication, 2018–2026
15.4. Market Attractiveness Analysis By Indication

16. Global Progressive Multifocal Leukoencephalopathy Treatment Market Analysis 2013-2017and Forecast 2018–2026, By Distribution Channel
16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Mn) and Trend Analysis By Distribution Channel, 2013-2017
16.2.1. Hospital Pharmacies
16.2.2. Drug Stores
16.2.3. Retail Pharmacies
16.3. Market Size (US$ Mn) and Forecast By Distribution Channel, 2018–2026
16.4. Market Attractiveness Analysis By Distribution Channel

17. Global Progressive Multifocal Leukoencephalopathy Treatment Market Analysis 2013-2017and Forecast 2018–2026
17.1. Market Value Share Analysis By All Segment
17.2. Y-o-Y Growth Analysis By All Segment
17.3. Absolute $ Opportunity
17.4 Research Methodology

List of Table

List of Table

Table 01: North America Progressive Multifocal Leukoencephalopathy Treatment Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 02: North America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 03: North America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication Type
Table 04: North America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 05: Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 06: Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 07: Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication Type
Table 08: Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 09: Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 10: Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 11: Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication Type
Table 12: Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 13: Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 14: Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 15: Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication Type
Table 16: Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 17: Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 18: Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 19: Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication Type
Table 20: Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 21 : Global Progressive Multifocal Leukoencephalopathy Treatment  Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Region
Table 22: Global Progressive Multifocal Leukoencephalopathy Treatment  Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 23: Global Progressive Multifocal Leukoencephalopathy Treatment  Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Indication Type
Table 24: Global Progressive Multifocal Leukoencephalopathy Treatment  Market Value  (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel

List of Chart

List of Figures

Figure 01: Global Progressive Multifocal Leukoencephalopathy Treatment Market Split By Drug Type (2018)
Figure 02: Global Progressive Multifocal Leukoencephalopathy Treatment Market Split By Indication Type (2018)
Figure 03: Global Progressive Multifocal Leukoencephalopathy Treatment Market Value 2018 & 2026
Figure 04: Global Progressive Multifocal Leukoencephalopathy Treatment Market Split By Distribution Channel (2018)
Figure 05: Global Progressive Multifocal Leukoencephalopathy Treatment Market Split By Region (2018)
Figure 6: North America Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Drug Type (2018)
Figure 7: North America Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Indication Type (2018)
Figure 8: North America Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Distribution Channel (2018) 
Figure 9: North America Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Country (2018)
Figure 10: North America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 11 : North America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 12 : U.S. Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 13: U.S. Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 14 : Canada Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 15  : Canada Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 16 : North America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Anti-retroviral Therapy
Figure 17 : North America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Anti-retroviral Therapy
Figure 18 : North America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Antiviral/Anti JCV
Figure 19  : North America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Antiviral/Anti JCV
Figure 20 : North America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Other Symptomatic
Figure 21 : North America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Other Symptomatic
Figure 22 : North America Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Drug Type
Figure 23 : North America Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Indication
Figure 24 : North America Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 25 : North America Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Country
Figure 26: Latin America Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Drug Type (2018)
Figure 27: Latin America Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Indication Type (2018)
Figure 28: Latin America Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Distribution Channel (2018) 
Figure 29: Latin America Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Country (2018)
Figure 30 : Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 31 : Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 32 : Brazil Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 33: Brazil Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 34 : Mexico Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 35: Mexico Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 36 : Rest of Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 37 : Rest of Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 38 : Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Anti-retroviral Therapy
Figure 39 : Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Anti-retroviral Therapy
Figure 40 : Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Antiviral/Anti JCV
Figure 41 : Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Antiviral/Anti JCV
Figure 42 : Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Other Symptomatic
Figure 43 : Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Other Symptomatic
Figure 44 : Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Drug Type
Figure 45 : Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Indication
Figure 46 : Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 47 : Latin America Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Country
Figure 48: Europe Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Drug Type (2018)
Figure 49: Europe Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Indication Type (2018)
Figure 50: Europe Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Distribution Channel (2018) 
Figure 51: Europe Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Country (2018)
Figure 52 : Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 53 : Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 54 : Germany Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 55 : Germany Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 56 : Italy Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 57 : Italy Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 58 : France Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 59 : France Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 60 : U.K. Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 61 : U.K. Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 62 : Spain Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 63 : Spain Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 64 : Russia Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 65 : Russia Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 66 : Rest of Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 67 : Rest of Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 68 : Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Anti-retroviral Therapy
Figure 69 : Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Anti-retroviral Therapy
Figure 70 : Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Antiviral/Anti JCV
Figure 71 : Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Antiviral/Anti JCV
Figure 72 : Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Other Symptomatic
Figure 73 : Europe Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Other Symptomatic
Figure 74 : Europe Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Drug Type
Figure 75 : Europe Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Indication
Figure 76 : Europe Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 77 : Europe Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Country
Figure 78: Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Drug Type (2018)
Figure 79: Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Indication Type (2018)
Figure 80: Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Distribution Channel (2018) 
Figure 81: Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Country (2018)
Figure 82 : Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 83 : Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 84 : China Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 85 : China Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 86 : India Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 87  : India Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 88 : Australia Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 89 : Australia Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 90 : Japan Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 91 : Japan Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 92: ASEAN Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 93: ASEAN Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 94: Rest of Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 95 : Rest of Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 96 : Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Anti-retroviral Therapy
Figure 97 : Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Anti-retroviral Therapy
Figure 98 : Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Antiviral/Anti JCV
Figure 99 : Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Antiviral/Anti JCV
Figure 100  : Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Other Symptomatic
Figure 101  : Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Other Symptomatic
Figure 102: Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Drug Type
Figure 103: Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Indication
Figure 104: Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 105: Asia Pacific Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Country
Figure 106 : Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Drug Type (2018)
Figure 107 : Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Indication Type (2018)
Figure 108 : Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Distribution Channel (2018) 
Figure 109 : Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment  Market Value Share, By Country (2018)
Figure 110: Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 111: Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 112 : GCC Countries Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 113 : GCC Countries Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 114 : South Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 115 : South Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 116: Rest of Middle East and Africa Countries Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017
Figure 117: Rest of Middle East and Africa  Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026`
Figure 118: Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Anti-retroviral Therapy
Figure 119: Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Anti-retroviral Therapy
Figure 120: Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Antiviral/Anti JCV
Figure 121 : Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Antiviral/Anti JCV
Figure 122: Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) Analysis, 2013–2017, By Other Symptomatic
Figure 123 : Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Other Symptomatic
Figure 124: Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Drug Type
Figure 125 : Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Indication
Figure 126: Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 127: Middle East & Africa Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Country
Figure 128: Global Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Region
Figure 129: Global Adult Hemoglobinopathy Testing Market Share Analysis (%) By Drug Type, 2018 & 2026
Figure 130: Global Adult Hemoglobinopathy Testing Market Y-o-Y Growth (%) By Drug Type, 2018–2026
Figure 131: Global Progressive Multifocal Leukoencephalopathy Treatment Market Attractiveness Analysis, By Drug Type
Figure 132: Global Progressive Multifocal Leukoencephalopathy Treatment Market Share Analysis (%) By Indication Type , 2018 & 2026
Figure 133: Global Progressive Multifocal Leukoencephalopathy Treatment Market Y-o-Y Growth (%) By Indication Type , 2018–2026
Figure 134: Global Progressive Multifocal Leukoencephalopathy Treatment  Market Attractiveness Analysis, By Indication Type 
Figure 135: Global Adult Hemoglobinopathy Testing Market Share Analysis (%) By Distribution Channel, 2018 & 2026
Figure 136: Global Adult Hemoglobinopathy Testing Market Y-o-Y Growth (%) By Distribution Channel, 2018–2026
Figure 137: Global Progressive Multifocal Leukoencephalopathy Treatment  Market Attractiveness Analysis, By Distribution Channel 
Figure 138: Global Progressive Multifocal Leukoencephalopathy Treatment Market Value Analysis and Forecast, 2018–2026 (US$ Mn)
Figure 139: Global Progressive Multifocal Leukoencephalopathy Treatment Market Absolute $ Opportunity (US$ Mn), 2013–2017
Figure 140: Global Progressive Multifocal Leukoencephalopathy Treatment Market Absolute $ Opportunity (US$ Mn), 2018–2026

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *